A detailed history of Moser Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moser Wealth Advisors, LLC holds 6,547 shares of GILD stock, worth $641,867. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,547
Previous 6,847 4.38%
Holding current value
$641,867
Previous $573,000 5.41%
% of portfolio
0.32%
Previous 0.3%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$83.95 - $97.9 $25,185 - $29,370
-300 Reduced 4.38%
6,547 $604,000
Q3 2024

Nov 05, 2024

SELL
$66.59 - $83.99 $16,980 - $21,417
-255 Reduced 3.59%
6,847 $573,000
Q2 2024

Aug 06, 2024

SELL
$63.15 - $72.88 $319,223 - $368,408
-5,055 Reduced 41.58%
7,102 $487,000
Q1 2024

May 01, 2024

SELL
$71.58 - $87.29 $223,973 - $273,130
-3,129 Reduced 20.47%
12,157 $890,000
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $92,320 - $104,693
-1,260 Reduced 7.62%
15,286 $1.24 Million
Q3 2023

Nov 09, 2023

SELL
$73.94 - $80.67 $18,485 - $20,167
-250 Reduced 1.49%
16,546 $1.24 Million
Q2 2023

Aug 02, 2023

SELL
$76.01 - $86.7 $52,066 - $59,389
-685 Reduced 3.92%
16,796 $1.29 Million
Q4 2022

Jan 12, 2023

SELL
$62.32 - $89.47 $52,161 - $74,886
-837 Reduced 4.57%
17,481 $1.5 Million
Q3 2022

Nov 03, 2022

SELL
$59.54 - $68.01 $14,706 - $16,798
-247 Reduced 1.33%
18,318 $1.13 Million
Q2 2022

Aug 02, 2022

SELL
$57.72 - $65.01 $11,428 - $12,871
-198 Reduced 1.06%
18,565 $1.15 Million
Q1 2022

Apr 29, 2022

BUY
$57.92 - $72.58 $18,128 - $22,717
313 Added 1.7%
18,763 $1.12 Million
Q4 2021

Jan 19, 2022

SELL
$64.88 - $73.64 $226,950 - $257,592
-3,498 Reduced 15.94%
18,450 $1.34 Million
Q3 2021

Oct 18, 2021

SELL
$67.69 - $73.03 $9,070 - $9,786
-134 Reduced 0.61%
21,948 $1.53 Million
Q2 2021

Jul 29, 2021

SELL
$63.47 - $69.35 $60,169 - $65,743
-948 Reduced 4.12%
22,082 $1.52 Million
Q1 2021

May 05, 2021

SELL
$60.0 - $68.46 $50,880 - $58,054
-848 Reduced 3.55%
23,030 $1.49 Million
Q4 2020

Jan 29, 2021

SELL
$56.65 - $64.55 $21,357 - $24,335
-377 Reduced 1.55%
23,878 $1.39 Million
Q3 2020

Oct 26, 2020

SELL
$62.1 - $78.08 $21,610 - $27,171
-348 Reduced 1.41%
24,255 $1.53 Million
Q2 2020

Jul 22, 2020

BUY
$72.34 - $84.0 $14,612 - $16,968
202 Added 0.83%
24,603 $1.89 Million
Q1 2020

Apr 30, 2020

SELL
$62.63 - $80.22 $106,846 - $136,855
-1,706 Reduced 6.53%
24,401 $1.82 Million
Q4 2019

Feb 12, 2020

BUY
$61.62 - $67.78 $1.61 Million - $1.77 Million
26,107 New
26,107 $1.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Moser Wealth Advisors, LLC Portfolio

Follow Moser Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moser Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moser Wealth Advisors, LLC with notifications on news.